MR Flanagan, AM Botty van den Bruele, SM Downs-Canner, SM Thomas, KK Gallagher, JW Jakub, SEA Tevis, FC Verdial, JQ Zhang, LC Elmore, RA Mukhtar, M Brennan, M Lillie, TC Gibson, A Verosky, JK Plichta, LH Rosenberger A Multi-Institutional Analysis of Contralateral Axillary Metastases: Advanced Local-Regional Disease Divergent from Stage IV Breast Cancer , Annals of Surgical Oncology, 32(8): 2025,551-5562
IC Yoon, S Perez-Rojas, B Ancha, LC Elmore, AM Mateo, MS Pichardo, JC Tchou, JQ Zhang, RA Hubbard, OM Fayanju Association of Neighborhood Deprivation with Stage at Diagnosis and Treatment Delay for Breast Cancer in Philadelphia , Annals of Surgical Oncology, 32: 2025,5500–5509
KP Reddy, CL Berkowitz, K Jarrell, R Berger, S Hulse, LC Elmore, R Fishman, AM Mateo, DM Sataloff, JC Tchou, JQ Zhang, AM McCarthy, OM Fayanju The Effect of Rurality on Time to Surgery and Overall Survival among Women with Breast Cancer , Annals of Surgery: 2025
Zhang JQ, Dos Anjos CH, Sevilimedu V, Crown A, Amoroso KA, Pilewskie ML, Robson ME, Gemignani ML Association of moderate-risk breast cancer genes with contralateral prophylactic mastectomy and bilateral disease , Annals of Surgical Oncology, 30(12): 2023,6990-6999
Manik R, Grady CB, Elmore LC, Fieber JH, Freedman GM, Jankowitz RC, Tchou JC, Zhang JQ, Hubbard RA, Fayanju OM Temporal trends and factors associated with receipt of post-mastectomy radiation after neoadjuvant chemotherapy in women with cT3 breast cancer , Annals of Surgical Oncology, 30(11): 2023,6506-6515
Pichardo MS, Zhang JQ, Fayanju OM Will targeted axillary surgery suffice for adjuvant treatment decision-making? , JAMA Surgery, 158(10): 2023,1021-1022
Rossi F, Liu M, Tieniber A, Etherington M, Hanna A, Vitiello G, Param N, Do K, Wang L, Antonescu C, Zeng S, Zhang JQ, DeMatteo RP Myosin light-chain kinase inhibition potentiates the antitumor effects of Avapritinib in PDGFRA D842V-mutant gastrointestinal stromal tumor , Clinical Cancer Research, 29(11): 2023,2144-2157
Zhang J, Lanchoney O, Joshi, Markosyan, Vonderheide RV CD40 agonism inhibits tumor growth in murine hormone receptor positive breast cancer via CD8 T cells , Cancer Immunology Research, 10(12 Suppl): 2022
Montagna G, Zhang J, Sevilimedu V, Charyn J, Abbate K, Gomez E, Mehrara B, Morrow M, Barrio AV Risk factors and racial and ethnic disparities in patients with breast cancer-related lymphedema , JAMA Oncology, 8(8): 2022,1195-1200
Zhang J, Dos Anjos C, Sevilimedu V, Crown A, Amoroso K, Zamau U, Pilewskie M, Gemignani ML, Robson M Association of moderate risk breast cancer genes with contralateral prophylactic mastectomy and bilateral disease , Annals of Surgical Oncology, 29(Suppl 2): 2022,S407-S408